Decreased S Phase and G2/M Phase Cells by a Bioactive Fraction from the Hexane Extract of Rhododendron aroboreum Leading to the Apoptosis of HeLa Cells In-Vitro
DOI:
https://doi.org/10.48048/tis.2022.4963Keywords:
R. aroboreum, Anti-cancer, S phase cells, Caspase-9, ApoptosisAbstract
Search for novel anticancer compounds from natural sources is a priority goal of cancer biologists. Rhododendron arboreum is one of the most stately and impressive Rhododendron species. In hilly areas, the flowers of R. arboreum are used for the treatment of chronic diseases. The current study was aimed to evaluate the anti-proliferative property of R. arboreum on HeLa cells. Crude extract of the flower was prepared using serial extraction procedure with different solvents. Cytotoxicity of the extracts on HeLa, CHO and human lymphocytes were assessed using MTT assay and trypan blue dye exclusion methods. The extract was further purified by TLC and characterized by LC-MS method. The hexane extract showed significant cytotoxicity to HeLa cells. This extract was fractionated using thin layer chromatography, 6 fractions were isolated, out of which fraction 3 showed the maximum cytotoxic activity with an IC50 of 15 μg/mL. The mechanism of action was observed as apoptosis induction as indicated by elevated caspase activity and inhibition of cell cycle with reduced cell population in the S and G2/M phases. LC-MS analysis of this promising bioactive fraction resulted in a molecular ion fragment with an m/z value of 437.48 which is corresponding to that of brefeldin A, an anticancer compound. It can be concluded that R. arboreum flower has cytotoxic activity which could be due to the presence of brefeldin A, that warrants further studies on purification and characterization towards the development of highly efficient therapeutics for cancer.
HIGHLIGHTS
- Anti-cancer drug discovery from natural sources like medicinal herbs having diverse metabolites of therapeutic significance provide lead molecules towards cancer drug development
- The anti-proliferative/apoptotic potential of a bioactive fraction from Rhododendron aroboreum, was analysed on cancer cell lines by MTT, Lactate dehydrogenase, Caspase and cell cycle studies. The bioactive compound was characterized through preparative TLC and LC-MS methods
- The potent apoptotic potential of Rhododendron aroboreum flower extract was demonstrated through reduced S-phase and G2/M phase cells, increased caspase, LDH activities in our study results
- The presence of Brefeldin A, previously reported as an anticancer compound in a microbe, was observed for the 1st time in Rhododendron aroboreum through our study in LC-MS analysis
GRAPHICAL ABSTRACT
Downloads
Metrics
References
DJ Newman and GM Cragg. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 2020; 83, 770-803.
P Srivastava. Rhododendron arboreum: An overview. J. Appl. Pharm. Sci. 2012; 2, 158-62.
PK Sonar, R Singh, S Khan and SK Saraf. Isolation, characterization and activity of the flowers of Rhododendron arboreum (Ericaceae). J. Chem. 2012; 9, 631-6.
R Popescu and B Kopp. The genus Rhododendron: An ethnopharmacological and toxicological review. J. Ethnopharmacol. 2013; 147, 42‑62.
S Ali, M Nisar, M Qaisar, A Khan and AA Khan. Evaluation of the cytotoxic potential of a new pentacyclic triterpene from Rhododendron arboreum stem bark. Pharma. Biol. 2017; 55, 1927-30.
V Gautam, A Sharma, S Arora, R Bhardwaj, A Ahmad, B Ahamad and P Ahmad. In-vitro antioxidant, antimutagenic and cancer cell growth inhibition activities of Rhododendron arboretum leaves and flowers. Saudi J. Biol. Sci. 2020; 27, 1788-96.
VM Duraipandiyan, S Ayyanar and S Ignacimuthu. Antimicrobial activity of some ethnomedicinal plants used by Paliyar tribe from Tamil Nadu, India. BMC Complement. Med. Ther. 2006; 6, 35.
ICMR. National ethical guidelines for biomedical and health research involving human participants. Indian Council of Medical Research, New Delhi, India, 2017, p. 187.
T Mosmann. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays. J. Immunol. Methods 1983; 16, 55-63.
JG Kirchner. Thin-layer chromatographic quantitative analysis. J. Chromatogr. A 1973; 82, 101-15.
KA Gomez and A Gomez. A statistical procedure for agricultural research. 2 Eds. John Willy and Sons, 1984, p.188.
Z Xiong and KJ Hale. Total synthesis of the antitumor macrolides, (+)-brefeldin A and 4-epi-brefeldin A from d-glucose: Use of the Padwa anionic Allenylsulfone [3 + 2]-cycloadditive elimination to construct trans-configured chiral cyclopentane systems. Org. Lett. 2016, 18, 4254-57.
S Painuli, S Joshi, A Bhardwaj, RC Meena, K Misra, N Rai and N Kumar. In vitro antioxidant and anticancer activities of leaf extracts of Rhododendron arboreum and Rhododendron campanulatum from Uttarakhand region of India. Phcog. Mag. 2018; 14, S294-303.
SK Madhvi, M Sharma, J Iqbal and M Younis. Phytochemistry, traditional uses and pharmacology of Rhododendron arboreum: A review. Res. J. Pharm. Technol. 2019; 12, 4565-74.
SM Paek. Recent synthesis and discovery of brefeldin A analogs. Mar. Drugs 2018; 16, 133.
A Swaroop, AP Gupta and AK Sinha. Simultaneous determination of quercetin, rutin and coumaric acid in flowers of Rhododendron arboreum by HPTLC. Chromatographia 2005; 62, 649‑52.
S Ali, M Nisar, M Qaisar, A Khan and AA Khan. Evaluation of the cytotoxic potential of a new pentacyclic triterpene from Rhododendron arboreum stem bark. Pharma. Biol. 2017; 55, 1927-30.
Z Hu, L Qin, W Ding, Y Liu and Z Ma. New analogues of brefeldin a from sediment-derived fungus Penicillium sp. DT-F29. Nat. Prod. Res. 2016; 30, 2311-15.
DE Larsson, M Wickstrom, S Hassan, K Oberg and D Granberg. The cytotoxic agents NSC-95397, brefeldin A, bortezomib and sanguinarine induce apoptosis in neuroendocrine tumors in vitro. Anticancer Res. 2010; 30, 149-56.
JL Moon, SY Kim, SW Shin and J Park. Regulation of brefeldin A-induced ER stress and apoptosis by mitochondrial NADP+-dependent isocitrate dehydrogenase. Biochem. Biophys. Res. Commun. 2012; 417, 760-4.
GM Cragg and DJ Newman. Natural products: A continuing source of novel drug leads. Biochem. Biophys. Acta 2013; 1830, 3670-95.
DJ Newman and GM Cragg. Plant endophytes and epiphytes: Burgeoning sources of known and “unknown” cytotoxic and antibiotic agents? Planta Med. 2020; 86, 891-905.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
